Stevanato Group SpA STVN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Stevanato Group Will Introduce Its Large-Volume Vertiva® 10mL On-Body Delivery System Platform for Injectable Therapies at CPHI Milan
-
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”
-
Stevanato Group to Present at Upcoming Investor Conferences
-
Stevanato Group Reports Financial Results for the Second Quarter of 2024
-
Stevanato Group to Report Second Quarter 2024 Financial Results on August 6, 2024
Trading Information
- Previous Close Price
- $19.66
- Day Range
- $18.86–20.25
- 52-Week Range
- $16.56–35.56
- Bid/Ask
- $19.00 / $30.43
- Market Cap
- $6.12 Bil
- Volume/Avg
- 631,151 / 543,675
Key Statistics
- Price/Earnings (Normalized)
- 34.25
- Price/Sales
- 4.31
- Dividend Yield (Trailing)
- 0.30%
- Dividend Yield (Forward)
- 0.30%
- Total Yield
- 0.30%
Company Profile
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 5,635
- Website
- https://www.stevanatogroup.com
Comparables
Valuation
|
Metric
|
STVN
|
688253
|
DIA
|
|---|---|---|---|
Price/Earnings (Normalized) | 34.25 | 21.74 | 20.77 |
Price/Book Value | 4.31 | 3.00 | 3.36 |
Price/Sales | 4.31 | 8.86 | 4.88 |
Price/Cash Flow | 34.07 | 17.00 | 17.67 |
Price/Earnings
STVN
688253
DIA
Financial Strength
|
Metric
|
STVN
|
688253
|
DIA
|
|---|---|---|---|
Quick Ratio | 1.13 | 15.40 | 1.67 |
Current Ratio | 1.74 | 15.84 | 3.12 |
Interest Coverage | 33.56 | 2,238.82 | 10.35 |
Quick Ratio
STVN
688253
DIA
Profitability
|
Metric
|
STVN
|
688253
|
DIA
|
|---|---|---|---|
Return on Assets (Normalized) | 4.56% | 12.17% | 6.48% |
Return on Equity (Normalized) | 7.84% | 13.13% | 12.05% |
Return on Invested Capital (Normalized) | 6.38% | 12.68% | 10.14% |
Return on Assets
STVN
688253
DIA
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| Pcmlzlcqk | Swm | $171.3 Bil | |||
| Becton Dickinson & Co
BDX
| Sqwhllmd | Sccyq | $68.9 Bil | |||
| Alcon Inc
ALC
| Smjzlprpj | Twmzzh | $48.1 Bil | |||
| ResMed Inc
RMD
| Rwghrwzll | Kbdqpln | $34.3 Bil | |||
| Coloplast AS ADR
CLPBY
| Ywjvjbdcpc | Yhvc | $28.7 Bil | |||
| West Pharmaceutical Services Inc
WST
| Fkklxmhv | Zdyx | $21.5 Bil | |||
| The Cooper Companies Inc
COO
| Wzhxzrk | Kcdrfjn | $21.1 Bil | |||
| Hologic Inc
HOLX
| Tgvksfjq | Hybbyt | $18.6 Bil | |||
| Baxter International Inc
BAX
| Bhjygfxb | Flbhwtz | $18.5 Bil | |||
| Align Technology Inc
ALGN
| Ftktqyhn | Zvflhmk | $18.0 Bil |
United States